Mycological Testing Market - Global Opportunity Analysis and Industry Forecast, 2019-2026

Diagnostics and Biotech	LI_184849	Pages: NA	Dec 2019 \| 397 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

CHAPTER 4 MYCOLOGICAL TESTING MARKET, BY TECHNOLOGY

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ELISA
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast by region
4.2.3. Market size and forecast by country
4.3. RAPID TESTS
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast by region
4.3.3. Market size and forecast by country
4.4. ELISPOT
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast by region
4.4.3. Market size and forecast by country
4.5. POLYMERASE CHAIN REACTION (PCR)
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast by region
4.5.3. Market size and forecast by country

CHAPTER 5 MYCOLOGICAL TESTING MARKET, BY END USER

5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Market size and forecast by region
5.2.2. Market size and forecast by country
5.3. CLINICAL LABORATORIES
5.3.1. Market size and forecast by region
5.3.2. Market size and forecast by country
5.4. RESEARCH CENTERS
5.4.1. Market size and forecast by region
5.4.2. Market size and forecast by country
5.5. OTHERS
5.5.1. Market size and forecast by region
5.5.2. Market size and forecast by country

CHAPTER 6 MYCOLOGICAL TESTING MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends, growth factors and opportunities
6.2.2. North America mycological testing market, by country
6.2.2.1. U.S. mycological testing market
6.2.2.1.1. U.S. market, by technology
6.2.2.1.2. U.S. market, by end user
6.2.2.2. Canada mycological testing market
6.2.2.2.1. Canada market, by technology
6.2.2.2.2. Canada market, by end user
6.2.2.3. Mexico mycological testing market
6.2.2.3.1. Mexico market, by technology
6.2.2.3.2. Mexico market, by end user
6.2.3. North America mycological testing market, by technology
6.2.4. North America mycological testing market, by end user
6.3. EUROPE
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Europe Mycological testing market, by country
6.3.2.1. Germany mycological testing market
6.3.2.1.1. Germany market, by technology
6.3.2.1.2. Germany market, by end user
6.3.2.2. France mycological testing market
6.3.2.2.1. France market, by technology
6.3.2.2.2. France market, by end user
6.3.2.3. UK mycological testing market
6.3.2.3.1. UK market, by technology
6.3.2.3.2. UK market, by end user
6.3.2.4. Italy mycological testing market
6.3.2.4.1. Italy market, by technology
6.3.2.4.2. Italy market, by end user
6.3.2.5. Spain mycological testing market
6.3.2.5.1. Spain market, by technology
6.3.2.5.2. Spain market, by end user
6.3.2.6. Rest of Europe mycological testing market
6.3.2.6.1. Rest of Europe market, by technology
6.3.2.6.2. Rest of Europe market, by end user
6.3.3. Europe mycological testing market, by technology
6.3.4. Europe mycological testing market, by end user
6.4. ASIA-PACIFIC
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Asia-Pacific Mycological testing market, by country
6.4.2.1. Japan mycological testing market
6.4.2.1.1. Japan market, by technology
6.4.2.1.2. Japan market, by end user
6.4.2.2. China mycological testing market
6.4.2.2.1. China market, by technology
6.4.2.2.2. China market, by end user
6.4.2.3. Australia mycological testing market
6.4.2.3.1. Australia market, by technology
6.4.2.3.2. Australia market, by end user
6.4.2.4. India mycological testing market
6.4.2.4.1. India market, by technology
6.4.2.4.2. India market, by end user
6.4.2.5. South Korea mycological testing market
6.4.2.5.1. South Korea market, by technology
6.4.2.5.2. South Korea market, by end user
6.4.2.6. Rest of Asia-Pacific mycological testing market
6.4.2.6.1. Rest of Asia-Pacific market, by technology
6.4.2.6.2. Rest of Asia-Pacific market, by end user
6.4.3. Asia-Pacific mycological testing market, by technology
6.4.4. Asia-Pacific mycological testing market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. LAMEA Mycological testing market, by country
6.5.2.1. Brazil mycological testing market
6.5.2.1.1. Brazil market, by technology
6.5.2.1.2. Brazil market, by end user
6.5.2.2. Saudi Arabia mycological testing market
6.5.2.2.1. Saudi Arabia market, by technology
6.5.2.2.2. Saudi Arabia market, by end user
6.5.2.3. South Africa mycological testing market
6.5.2.3.1. South Africa market, by technology
6.5.2.3.2. South Africa market, by end user
6.5.2.4. Rest of LAMEA mycological testing market
6.5.2.4.1. Rest of LAMEA market, by technology
6.5.2.4.2. Rest of LAMEA market, by end user
6.5.3. LAMEA mycological testing market, by technology
6.5.4. LAMEA mycological testing market, by end user

CHAPTER 7 COMPANY PROFILES

7.1. F. HOFFMANN-LA ROCHE LTD
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. ABBOTT LABORATORIES, INC.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. SIEMENS AG
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. BECKMAN COULTER, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ORTHO-CLINICAL DIAGNOSTICS, INC.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. BIOMÉRIEUX SA
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. ELITECHGROUP
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. MIRAVISTA DIAGNOSTICS
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. ALS
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. BCN RESEARCH LABORATORIES, INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,110 Data Pack/Excel ~~$3,840~~ $3,456 Single User License ~~$5,370~~ $4,833 Five User License ~~$6,450~~ $5,805 Enterprise User License ~~$8,995~~ $8,096

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285, Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry